Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01960465 · ClinicalTrials.gov registry record · NA

Race And CPAP Effectiveness

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
220
Enrollment target

NCT01960465: Completed NA study, sponsored by VA Office of Research and Development.

NCT01960465 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01960465, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target

Study Summary

Obstructive sleep apnea (OSA) is a major public health problem in the U.S. and more than 35% of Veterans are at high risk for OSA. OSA is associated with progression of hypertension, an important health problem in Veterans. African Americans with OSA are at increased risk for poorly controlled hypertension and its health consequences. Implementing a care plan to increase the percentage of Veterans in whom blood pressure goals are achieved has been prioritized by Veterans Administration hospitals. Recent studies show that hypertension control can be improved with continuous positive airway pressure (CPAP) treatment of OSA. The aim of this proposal is to examine and compare the effects of CPAP treatment on 24-hour arterial blood pressure and central aortic blood pressure (measured non-invasively with a cuff on the upper arm) in African American and other Veterans.

Interventions

  • DEVICE Continuous positive airway pressure

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2015-01-05
Est. Completion 2019-08-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01960465

The ClinicalTrials.gov registry entry for NCT01960465 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Continuous positive airway pressure is the first listed.

NCT01960465 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01960465 about?

NCT01960465 is a clinical study titled "Race And CPAP Effectiveness". Obstructive sleep apnea (OSA) is a major public health problem in the U.S. and more than 35% of Veterans are at high risk for OSA. OSA is associated with progression of hypertension, an important health problem in Veterans. African Americans with OSA are at increased risk for poorly controlled hyper...

What is the current status of trial NCT01960465?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2015-01-05. Estimated completion is 2019-08-30.

What interventions are being tested in trial NCT01960465?

The interventions under investigation include: Continuous positive airway pressure (DEVICE).

Who is sponsoring clinical trial NCT01960465?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.